Stephen Van Deventer

Executive

CA·SEDI

PreveCeutical Medical Inc.BioGene Therapeutics Inc.

Total declarations

Companies

▲ Purchases (0 ops.)

—

▼ Sales (0 ops.)

—

Latest filing published 10 Jun 2026 for BioGene Therapeutics Inc.. Read the official filing

Insider track record

Disclosed buys

Disclosed sells

Signal history

No signal scores available.

Stephen Van Deventer: trading record in brief

Stephen Van Deventer is a declared insider at 2 companies; the most frequent names are BioGene Therapeutics Inc. and PreveCeutical Medical Inc. We count 2 filings; the first trade dates from 19 May 2017 and the latest from 21 October 2024.

The filings describe grants, exercises and other transfers rather than trades on the open market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.

On 10 June 2026 came the latest disclosure, a transaction in BioGene Therapeutics Inc. This summary is built from SEDI disclosures alone and does not predict where the share price will go.